期刊文献+

MK801拮抗脑缺血导致的Ca^(2+)/CaMPKⅡ活性抑制 被引量:2

ANTAGONIZATION OF MK801 AGAINST INHIBITION OF Ca^2+/CaM PK Ⅱ ACTIVITY INDUCED BY CEREBRAL ISCHEMIA
下载PDF
导出
摘要 目的研究脑缺血兴奋毒性与Ca2+/CaMPKⅡ的关系。方法采用离体孵育的大鼠海马脑片制备“缺血”模型。采用32P标记,滤纸片吸附法测定Ca2+/CaMPKⅡ活性。结果①Ca2+/CaMPKⅡ活性随“缺血”时间延长而降低,“缺血”30min可降至正常的16.4%;②单纯过量外源性谷氨酸作用30min可导致Ca2+/CaMPKⅡ活性降低;无胞外Ca2+时,谷氨酸导致的酶活性抑制程度不如有胞外Ca2+时显著;③MK801对“缺血”导致的Ca2+/CaMPKⅡ活性抑制有部分拮抗作用,25μmol/LMK801可使“缺血”30min的Ca2+/CaMPKⅡ活性恢复至正常的43.8%。结论脑缺血导致的Ca2+/CaMPKⅡ活性抑制可被MK801部分拮抗,说明其活性抑制与NMDA受体介导的兴奋性毒性作用有关。 Objective To study the relation between Ca^2+/CaM PK Ⅱ and cerebral ischemia. Methods Studying in an in vitro model of rat hippocampal slice. Results (1)Ca^2+/CaM PK Ⅱ activity decreased with ischemic time increasing, and fell to 16.4% of control at 30 min of ischemia.(2)Treatment with excessive exogenous glutamate for 30 min induced inhibition of Ca^2+/CaM PK Ⅱ activity,and inhibition of the enzyme activity in the absence of extracellular Ca^2+ was less than that in existance of extracellular Ca^2+. (3) 25μmol/L MK801 recovered Ca^2+/CaM PK Ⅱactivity from 16.4% to 43.8% of control at 30 min of ischemia. Conclusions NMDA receptors play an important role in ischemia-induced inhibition of Ca^2+/CaM PK Ⅱ activity.
作者 冯霞 张光毅
出处 《徐州医学院学报》 CAS 1997年第6期6-10,共5页 Acta Academiae Medicinae Xuzhou
基金 国家自然科学基金
关键词 大鼠 海马脑片 缺血 MK801 钙/钙调素依赖性蛋白激酶Ⅱ Rat Hippocampal slice Ischemia MK801 Ca2+/CaM protein kinase Ⅱ
  • 相关文献

同被引文献27

  • 1吴波,刘鸣,张世洪.丹参类药物治疗急性缺血性脑卒中的系统评价[J].中国循证医学杂志,2005,5(2):101-105. 被引量:11
  • 2[6]DeGraba TJ, Pettigrew LC. Why do neuroprotective drugs work in animals but not humans[J]? Neurol Clin, 2000, 18(2) :475.
  • 3[7]Lyden P, Wahlgren NG.J Stroke Cerebrovasc Dis, 2000, 9(suppl 2):9.
  • 4[9]Hickks CA, Ward MA, Swettenham JB, et al. Synergistic neuroprotective effets by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischemia[J]. Eur J Pharmacol, 1999, 381(2-3):113.
  • 5[10]Liniger R, Popovic R, Sullivan B, et al. Effect of neuroprotective cocktails on hippocampal neuron death in viro model of cerebral ischemia[J] .J Neurosurg Anesthesiol, 2001, 13(1): 19.
  • 6Pulsinlli WA.Ischemic brain injury and the therapeuticwindow[J].Ann N Y Acad Sci,1997,835:187.
  • 7The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med, 1995,333:1581.
  • 8Stroke Therapy Academic Industry Roundtable(STAIR).Recommendations for standards regarding preclinical neuroprotective and development[J].Stroke, 1999,30:2752.
  • 9DeGraba TJ ,Pettigrew LC. Why do neuroprotective drugs work in animals but not humans[J]. Neurol Clin ,2000,18(2):475.
  • 10王永炎.关于提高脑血管疾病疗效难点的思考[J].中国中西医结合杂志,1997,17(4):195-196. 被引量:614

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部